Search Results 1761-1770 of 21411 for anti-TNF drugs

1. Combination Study of SV-BR-1-GM in Combination With INCMGA00012 and Retifanlimab - Mayo Clinic

   ... therapy and previously treated with at least 2 regimens including at least two anti-HER2 agents;; Patients who have failed therapy with at least two anti ...

2. Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Study - Mayo Clinic

   Patients with known human immunodeficiency virus (HIV) on effective anti-retroviral therapy with undetectable viral load within 6 months are eligible for ...

3. A Study to Investigate Intravenous Tocilizumab in Patients with Moderate-to-Severe COVID-19 Pneumonia (enrolling by invitation only) - Mayo Clinic

   Drugs & Supplements A-Z · Health Books · Healthy ... Participation in other drug clinical trials (participation in COVID-19 anti-viral trials may be permitted if ...

4. A Study to Analyze NMS-03305293 and Temozolomide in Adult Patients with Recurrent Glioblastoma - Mayo Clinic

   Treatment with enzyme-inducing anti-epileptic drugs (EIAED). Patients may be on non-EIAED or not be taking any anti-epileptic drugs. Patients previously ...

5. About Cancer Clinical Trials - Mayo Clinic Comprehensive Cancer Center Research

   Interventions studied in clinical trials might be new cancer medicines or new combinations of medicines, new medical procedures, new surgical techniques or ...

6. A Phase II, Multicenter Study of the EZH2 Inhibitor Tazemetostat in Adult Subjects With INI1-Negative Tumors or Relapsed/Refractory Synovial Sarcoma - Mayo Clinic

   ... drug or known bleeding diathesis or treatment with anti-platelet or anti-thrombotic agents. Has known hypersensitivity to any of the components of ...

7. Hypothyroidism: Does it cause joint pain? - Mayo Clinic

   But treatment with thyroid hormone replacement medicine typically is the most effective way to relieve the symptoms of hypothyroidism, including joint and ...

8. A Study to Assess Safety and Effectiveness of Venetoclax in Combination With Gilteritinib in Subjects With Relapsed/Refractory Acute Myeloid Leukemia - Mayo Clinic

   ... drug (venetoclax and gilteritinib). Subject cannot have received treatment with anti-leukemia therapy, including chemotherapy, radiotherapy or any ...

9. Safety and Efficacy of ALLO-715 and ALLO-647 BCMA Allogenic CAR T Cells in in Adults With Relapsed or Refractory Multiple Myeloma (UNIVERSAL) - Mayo Clinic

   - Prior treatment with anti-BCMA therapy, any gene therapy, any genetically modified cell therapy, or adoptive T cell therapy - History of HIV infection or ...

10. Taselisib and Enzalutamide in Treating Patients With Androgen Receptor Positive Triple-Negative Metastatic Breast Cancer - Mayo Clinic

    Drugs & Supplements A-Z · Health Books · Healthy Living Program · Mayo Clinic ... Concurrent anti-cancer therapy (chemotherapy, radiation therapy, surgery ...